State Of Tennessee, Treasury Department Organogenesis Holdings Inc. Transaction History

State Of Tennessee, Treasury Department

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jan 26, 2023	BUY	$3.14 - $6.43 $7,850 - $16,075	2,500 Added 6.0%	44,132 $143,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $1,692 - $2,909	-357 Reduced 0.85%	41,632 $203,000
Q1 2022 May 11, 2022	BUY	$6.47 - $9.57 $37,784 - $55,888	5,840 Added 16.16%	41,989 $320,000
Q4 2021 Feb 15, 2022	BUY	$9.02 - $13.5 $41,221 - $61,695	4,570 Added 14.47%	36,149 $334,000
Q3 2021 Nov 12, 2021	BUY	$13.71 - $17.18 $19,481 - $24,412	1,421 Added 4.71%	31,579 $451,000
Q2 2021 Aug 11, 2021	BUY	$14.92 - $23.23 $449,957 - $700,570	30,158 New	30,158 $501,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

Stay updated on State Of Tennessee, Treasury Department with notifications on news.